Results 311 to 320 of about 274,076 (393)

KEYNOTE‐A17: First‐Line Pembrolizumab Plus Cisplatin–Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma

Cancer Science, EarlyView.
In the phase 1b KEYNOTE‐A17 study of first‐line pembrolizumab plus chemotherapy in Japanese participants with advanced pleural mesothelioma (PM), 2 of 18 participants (11%) evaluated experienced dose‐limiting toxicities. The objective response rate among all 19 participants in the study was 74%, with 14 participants achieving a partial response and a ...
Takashi Kijima, Terufumi Kato, Yasushi Goto, Kozo Kuribayashi, Koji Mikami, Yoshiki Negi, Shuji Murakami, Tatsuya Yoshida, Masae Homma, Akira Wakana, Kazuo Noguchi, Nobukazu Fujimoto   +11 more
wiley   +1 more source

Role of gut microbiota in predicting chemotherapy-induced neutropenia duration in leukemia patients. [PDF]

Front Microbiol
Huang Y, Liao L, Jiang Y, Tao S, Tang D.
europepmc   +1 more source

Phase III Clinical Trial of KRN8601 (rhG-CSF) for Neutropenia in Patients with Human Immunodeficiency Virus Infection

, 1994
Satoshi Kimura, Kaoru Shimada, Jyuzo MATSUDA, Kengo Gohchi, Katsuyuki Fukutake, H Fukue, Takao Okubo, Yoshiaki Ishigatsubo, Kaneo Yamada, Yasushi Koitabashi, Masashi Taki, Fumiaki Sano, Yoshihiro Ueda, Atsushi Kuramoto, Noboru TAKATA, Mitsunobu AKASHI, Toshiyuki Nakayama   +16 more
openalex   +2 more sources

Real‐world outcomes of vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome at a tertiary referral centre

British Journal of Haematology, EarlyView.
Lucia Lee, Eric J. Zhao, Robert Schmidt, Alym Abdulla, Gayatri Sreenivasan, Kimberley Ambler, Megan Hiltz, Lynda Foltz, Vicki Chan, Alexandra Legge, Maggie Yuen, Lauren Lee, Paul Yenson, Thomas J. Nevill, Luke Y. C. Chen, Ryan J. Stubbins   +15 more
wiley   +1 more source

Pyrotinib and Nab‐Paclitaxel in HER2‐Positive Breast Cancer (PANHER Trial): A Prospective, Single‐Arm, Phase II Trial

Cancer Science, EarlyView.
In this multicenter, single‐arm, open‐label phase II trial, patients with HER2‐positive breast cancer who had previously received chemotherapy with taxanes or anthracyclines were enrolled to receive pyrotinib combined with nab‐paclitaxel, and the results demonstrated promising efficacy with an acceptable safety profile.
Huan Li, Min Yan, Zhaohui Li, Xiujie Cui, Xuening Ji, Fengqi Fang, Yuyang Zhang, Yan Wang, Xiangyu Guo, Mingxi Jing, Zhichao Gao, Hui Cao, Fangyuan Dong, Jie Wu, Cui Jiang, Yangyang Duan, Xiaorui Li, Yujun Jiang, Lei Jiang, Ying E, Yufeng Jia, Liang Zhang, Pai Peng, Tao Sun   +23 more
wiley   +1 more source

Parallel Toxicities: A Comparative Analysis of Chemotherapy-Induced Neutropenia and Alopecia. [PDF]

Cancers (Basel)
Gaumond SI, Lee KJ, Warp PV, Kamholtz I, Dreifus EM, Jimenez JJ.   +5 more
europepmc   +1 more source

Ubenimex treatment in congenital cyclic neutropenia.

, 1990
Morio Aihara, Keiko Sasaki, Yutaka Yoshida   +2 more
openalex   +2 more sources

Congenital neutropenias

Hematology, 2005
openaire   +2 more sources

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer

Cancer Science, EarlyView.
FOLFIRINOX improves the prognosis of patients with pancreatic cancer; however, despite UGT1A1 screening, adverse events, such as severe neutropenia, occur frequently. The diagnostic performance of the neutropenia prediction model showed areas under the curve of 0.754 (sensitivity=0.605, specificity=0.848) and 0.856 (sensitivity=0.800, specificity=0.893)
Gen Kanesada, Ryouichi Tsunedomi, Yuki Nakagami, Hiroto Matsui, Yoshitaro Shindo, Shinobu Tomochika, Hirofumi Akita, Tatsuya Ioka, Hidenori Takahashi, Hiroaki Nagano   +9 more
wiley   +1 more source

Efficacy and Safety of Amphotericin B Colloidal Dispersion for Patients with Invasive Fungal Disease and Febrile Neutropenia: A Registry-Based, Multicenter, Retrospective, Real-World Study. [PDF]

Infect Drug Resist
Zhang L, Zhang Q, Ma W, Chu ZB, Xu L, Xing H, Wang J, Lin J, Liu Z.   +8 more
europepmc   +1 more source